Registration Dossier
Registration Dossier
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 931-038-4 | CAS number: -
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data

Endpoint summary
Administrative data
Description of key information
No acute toxicity studies with n/i-C13-C15-aldehydes are available, but data from structurally closely related n-undecanal and 3,5,5,-trimethylhexanal are used for read-across.
The oral and dermal LD50 value were >5000 mg/kg bw in rats (oral) and rabbits (dermal).
Inhalation exposure is not regarded as being relevant because the very low vapour pressure will only lead to minor air concentrations.
Key value for chemical safety assessment
Acute toxicity: via oral route
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- discriminating dose
- Value:
- 5 000 mg/kg bw
Additional information
No acute toxicity studies with n/i-C13 -C15 -aldehydes are available. However, information from structurally closely related substances (saturated unbranched or branched long chain aldehydes; n-undecanal or n/i-undecanal and 3,5,5,-trimethylhexanal) are used for read-across. N-undecanal is readily metabolised via ß-oxidation like n/i-C13 -C15 -aldehydes, whereas the methyl groups at uneven positions inhibit ß-oxidation and detoxification of 3,5,5-trimethylhexanal may therefore be regarded to represent a worst case.
Oral route
N-Undecanal (purity: not stated) was administered to 5 male and 5 female Sprague-Dawley albino rats by gavage at the limit dose of 5000 mg/kg bw according to testing guideline OECD 401. Following dosing minor clinical signs (as e.g. hunched posture, pilo-erection as well as diarrhoea or ptosis) occurred, but were all reversible within 3 days. During the 14 days observation period no animal died. Subsequent gross pathology revealed congestions of the lungs in three rats, but no other macroscopic changes were seen. The given results lead to a LD50 > 5000 mg test item per kg bw (LD0 = 5000 mg/kg bw; Ruhrchemie AG/Safepharm, 1985).
3,5,5 -trimethylhexanal: When fasted rats were exposed to single oral doses of 2000 mg 3,5,5 -trimethylhexanal/kg bw, there were clinical signs of toxicity and increased mortality (1/10 animals died during 14 day observation period). The LD50 was > 2000 mg/kg bw (Hüls AG, 1997). The treatment of fasted rats with single oral doses resulted in clinical signs of toxicity and increased mortality. The LD50 was 5266 mg/kg bw (males/females), 4737 mg/kg bw (females) and 5848 mg/kg bw (males) (Hazleton Laboratories, 1982).
Based on the above, the acute oral LD50 of n/i-C13 -C15 -aldehydes in rats is considered to be >5000 mg/kg bw.
Inhalation
No valid study was located. The vapour pressure of n/i-C13 -C15 -aldehydes is very low, and therefore the saturation concentration is also low. Inhalation is therefore not considered to represent a relevant exposure route.
Dermal route
No deaths occurred in 3 rats that were dermally exposed for 24 hours to 5000 mg n-undecanal/kg bw (Shelanski and Moldova, 1971). This result can be read-across to n/i-C13 -C15 -aldehydes.
Justification for selection of acute toxicity – inhalation endpoint
Only two routes of exposure required. Inhalation route not relevant for this submission substance of low volatility (low vapour pressure (3 hPa) and high boiling point).
Justification for classification or non-classification
According to the criteria set in Regulation (EC) No 1272/2008 no classification for acute toxicity is required as available data from read-across substances indicate that oral and dermal LD50 values are above 5000 mg/kg.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.
